As a demonstration of responsibility for our products and concern for patients’ health, Kalceks conducts safety monitoring (pharmacovigilance) in all countries where our medicines are sold.
Kalceks and its mother company Grindeks maintains single pharmacovigilance system.
Task of pharmacovigilance division is to eliminate potential risk to patients, and detect of both positive and negative new effects.
Division is guided by Good Pharmacovigilance Practice and national legislation. Received information is verified, evaluated and reported when required.
If using or administering our drugs you notice side effect, lack of efficacy or other unusual reaction, please report it in the way most convenient for you
By post: Pharmacovigilance division, JSC Grindeks, Krustpils street 53, LV-1057, Riga, Latvia
We guarantee full confidentiality of your data!
We also invite to report about cases of inappropriate drug use!
If you want to report side effects on Kalceks drugs, we kindly advise you to use abovementioned options or fill form at homepage of mother company Grindeks:
Qualified person for pharmacovigilance
Direct telephone number: +371 22038854